NICE TAs
- 11/10/2021
- TA732: Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)
-
-
- 11/10/2021
- TA734: Secukinumab for treating moderate to severe plaque psoriasis in children and young people
-
-
- 16/12/2020
- TA666: Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma
-
-
- 18/11/2020
- TA659: Galcanezumab for preventing migraine
-
-
- 20/10/2020
- TA457: Carfilzomib for previously treated multiple myeloma
-
-
-
Evidence-based recommendations on carfilzomib (Kyprolis) for treating multiple myeloma in adults.
- 14/10/2020
- TA653: Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer
-
-
- 12/10/2020
- TA631: Fremanezumab for preventing migraine
-
-